Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Lynas Rare Earths Shares Surge on Strong Half-Year Earnings and Rising Global Demand
Samsung and SK Hynix Shares Hit Record Highs as Nvidia Earnings Boost AI Chip Demand
APEX Tech Acquisition Inc. Raises $111.97 Million in NYSE IPO Under Ticker TRADU
Trump Orders Federal Agencies to Halt Use of Anthropic AI Technology
Hyundai Motor Group to Invest $6.26 Billion in AI Data Center, Robotics and Renewable Energy Projects in South Korea
Boeing Secures $166.8 Million U.S. Navy Contract for P-8A Engineering and Software Support
Flare, Xaman Roll Out One-Click DeFi Vault for XRP Yield via XRPL Wallets
Netflix Stock Jumps 14% After Exiting Warner Bros Deal as Paramount Seals $110 Billion Acquisition
Trump Warns Iran as Gulf Conflict Disrupts Oil Markets and Global Trade
Snowflake Forecasts Strong Fiscal 2027 Revenue Growth as Enterprise AI Demand Surges
FAA Plans Flight Reductions at Chicago O’Hare as Airlines Ramp Up Summer Schedules
Panama Investigates CK Hutchison’s Port Unit After Court Voids Canal Contracts
Meta Signs Multi-Billion Dollar AI Chip Deal With Google to Power Next-Gen AI Models
Middle East Airspace Shutdown Disrupts Global Flights After U.S.-Israel Strikes on Iran
Amazon’s $50B OpenAI Investment Tied to AGI Milestone and IPO Plans
Toyota Plans $19 Billion Share Sale in Major Corporate Governance Reform Move 



